Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419

Audiocasts - Head and Neck Cancer, Audiocast

Carryn Anderson, MD, discusses the clinical significance of her research on, “Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419.”

Related Items
New Saliva Test Accurately Detects HPV-Associated Head and Neck Cancer
William King
TOP - November 2021 Vol 14, No 7 published on November 10, 2021 in Head and Neck Cancer
November 4, 2019 — Oncology News & Updates
Web Exclusives published on November 5, 2019 in Financial Toxicity, Head and Neck Cancer, Hematologic Cancers, In the News, Leukemia
Oral Cancer and Sex in the Era of HPV Infection
Meg Barbor, MPH
Web Exclusives published on October 28, 2019 in Head and Neck Cancer
Low Survival in Patients with Head and Neck Cancers Linked to Delays in Radiation Therapy After Surgery
Corbin Davis
TOP - August 2018, Vol 11, No 2 published on August 3, 2018 in Head and Neck Cancer
Low-Level Laser Therapy Reduces Pain in Patients with Head and Neck Cancer
Eric Allan, MD
Audiocasts published on July 22, 2016 in Head and Neck Cancer, Audiocast
Low-Level Laser Therapy Reduces Pain in Patients with Head and Neck Cancer
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 published on May 13, 2016 in Head and Neck Cancer
Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 published on May 13, 2016 in Head and Neck Cancer
Prophylactic Gabapentin Linked to Weight Loss, Narcotic Dependency
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 published on May 13, 2016 in Conference Correspondent, Head and Neck Cancer
Hepatotoxicity a Concern with Frontline Idelalisib
Jennifer Brown, MD, PhD
Audiocasts published on February 19, 2016 in Conference Correspondent, Audiocast
ASHP Foundation Forecast Provides Actionable Recommendations for Pharmacy Leaders
William A. Zellmer, BPharm, MPH
Audiocasts published on February 19, 2016 in Conference Correspondent, Audiocast
Last modified: July 22, 2021